Skin vascular disease
MONDO:0019293A disease that involves the superficial vasculature.
Also known as: skin vascular disorder, superficial vasculature disease, vascular disease of the skin, vascular skin disease, vasculature skin disease, disorder of blood vessels affecting skin, vascular disorder of skin, vascular disorders of skin
128 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
Could a simple pill shield HAE patients from Procedure-Triggered attacks?
Disease control Not yet recruitingThis trial tests whether the drug sebetralstat can prevent swelling attacks in people with hereditary angioedema (HAE) when taken before a medical procedure. Participants aged 12 and older with HAE type I or II will take sebetralstat just before their scheduled procedure. The mai…
Phase: PHASE4 • Sponsor: KalVista Pharmaceuticals, Ltd. • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Could a cream make laser treatment for birthmarks more effective?
Disease control Not yet recruitingThis study tests whether a rapamycin cream, applied after laser treatment, can improve the appearance of port wine stain birthmarks in children aged 10 and under. Thirty participants will receive laser therapy plus either a low or high dose of the cream or a placebo cream for 12 …
Phase: PHASE2 • Sponsor: AFT Pharmaceuticals, Ltd. • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Takhzyro under the microscope: Real-World safety check for rare swelling disease
Disease control Not yet recruitingThis study looks at how safe and effective Takhzyro is for teenagers and adults with hereditary angioedema (HAE) in everyday medical care in South Korea. HAE is a rare condition that causes sudden swelling under the skin or inside the body. The study will track side effects and h…
Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New hope for rare blood vessel disorders: everolimus trial launches
Disease control Not yet recruitingThis phase 2 trial tests the drug everolimus in 67 people with vascular anomalies (abnormal blood vessels) that haven't responded to standard treatments. The goal is to shrink the lesions and improve symptoms. Participants take everolimus daily for 6 months, with doses adjusted b…
Phase: PHASE2 • Sponsor: Yonsei University • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Sound waves vs. freezing: new skin cancer treatment tested
Disease control Not yet recruitingThis study tests whether high intensity focused ultrasound (HIFU) works as well as standard cryotherapy (freezing) for treating low-risk basal cell carcinomas and Bowen's disease. About 294 adults with small skin cancers on their body (not face or hands) will be randomly assigned…
Phase: NA • Sponsor: Jussi Salonen • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New laser trial aims to zap away redness and birthmarks
Symptom relief Not yet recruitingThis study will test a special laser called the Vbeam Pro on 40 adults with rosacea or port-wine stain birthmarks. The goal is to see if the laser can safely clear or improve these red skin conditions. Participants will receive laser treatments and be evaluated for changes in app…
Phase: NA • Sponsor: Candela Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 08:05 UTC
-
Immune clues in the blood may foretell heart trouble
Knowledge-focused Not yet recruitingThis study is building a biobank of blood samples and imaging data from 300 people with suspected inflammatory heart or autoimmune rheumatic diseases. Researchers aim to identify immune biomarkers that could predict major heart events like heart failure, stroke, or atrial fibrill…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Aug 12, 2026 00:00 UTC
-
Egyptian HAE patients to be studied for better care insights
Knowledge-focused Not yet recruitingThis study will collect information from medical records and routine clinic visits of 100 people in Egypt with hereditary angioedema (HAE) type I or II. The goal is to understand how the condition is diagnosed and managed in current medical practice. No new treatments are being t…
Sponsor: Takeda • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Can a quick skin scan reveal hidden inflammation in arthritis?
Knowledge-focused Not yet recruitingThis study will measure harmful molecules called AGEs in 300 people with various rheumatic diseases (like rheumatoid arthritis and ankylosing spondylitis) and compare them to healthy volunteers. AGEs build up over time and can cause inflammation. Researchers will use a non-invasi…
Sponsor: Bursa City Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC
-
New blood test could spot autoimmune diseases earlier
Knowledge-focused Not yet recruitingThis study will use a special blood test called mass spectrometry to look at immune cells in 500 people with various autoimmune diseases and healthy volunteers. The goal is to find patterns that could help doctors diagnose these conditions sooner. No treatments are being tested; …
Sponsor: Peking University People's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC
-
Egyptian study maps Behçet's disease patterns in 30 patients
Knowledge-focused Not yet recruitingThis study will observe 30 people with Behçet's disease at a hospital in Upper Egypt to learn more about their symptoms, lab results, and treatments. Researchers will track how often key signs like mouth ulcers, genital sores, and eye inflammation occur. The goal is to better und…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Jun 26, 2026 13:40 UTC